Skip to main content
. 2017 Jun 1;24(6):572–582. doi: 10.5551/jat.36327

Fig. 2.

Fig. 2.

The difference in LOX-1 expression between patients with ACI and healthy controls

(A) LOX-1 mRNA expression in patients with ACI and healthy controls. Data are expressed as mean ± SD, n = 120 in each group. LOX-1 mRNA expression in PBMCs was determined by real-time PCR and expressed as ratio of the control. **P < 0.01 vs. healthy controls. (B) LOX-1 protein expression in patients with ACI and healthy controls. Data are expressed as mean ± SD, n = 120 in each group. LOX-1 protein expression in PBMCs was measured by Western blot and expressed as ratio of the control. **P < 0.01 vs. healthy controls. ACI: atherosclerotic cerebral infarction patients and controls: healthy controls.